Zdrowie i gospodarka · 29/05/2026

FDA Announces Final Guidance on Statistical Approaches for Bioequivalence Studies

The Food and Drug Administration (FDA) has released a final guidance document providing recommendations for sponsors and applicants on statistical approaches for establishing bioequivalence in clinical trials, replacing previous versions issued in 2001 and 2022.